Loading...

MPH Health Care

XTRA:93M
Snowflake Description

Outstanding track record with adequate balance sheet.

The Snowflake is generated from 30 checks in 5 different areas, read more below.
93M
XTRA
€185M
Market Cap
  1. Home
  2. DE
  3. Pharmaceuticals & Biotech
Company description

MPH Health Care AG operates in the healthcare market in Germany. The last earnings update was 233 days ago. More info.


Add to Portfolio Compare Print
93M Share Price and Events
7 Day Returns
0.5%
XTRA:93M
-0.6%
DE Pharmaceuticals
1.8%
DE Market
1 Year Returns
-0.5%
XTRA:93M
-21.5%
DE Pharmaceuticals
-6%
DE Market
93M Shareholder Return
  7 Day 30 Day 90 Day 1 Year 3 Year 5 Year
MPH Health Care (93M) 0.5% 0.2% 1% -0.5% 64.3% -
DE Pharmaceuticals -0.6% -1.6% -2.3% -21.5% -26.2% 8.1%
DE Market 1.8% 4.6% 7.4% -6% 10.1% 15.3%
1 Year Return vs Industry and Market
  • 93M outperformed the Pharmaceuticals industry which returned -21.5% over the past year.
  • 93M outperformed the Market in Germany which returned -6% over the past year.
Price Volatility
93M
Industry
5yr Volatility vs Market

Value

 Is MPH Health Care undervalued based on future cash flows and its price relative to the stock market?

Value is all about what a company is worth versus what price it is available for. If you went into a grocery store and all the bananas were on sale at half price, they could be considered undervalued.
INTRINSIC VALUE BASED ON FUTURE CASH FLOWS
  • It is not possible to calculate the future cash flow value for MPH Health Care. This is due to cash flow or dividend data being unavailable. The share price is €4.23.
PRICE RELATIVE TO MARKET
We can also value a company based on what the stock market is willing to pay for it. This is similar to the price of fruit (e.g. Mangoes or Avocados) increasing when they are out of season, or how much your home is worth.

The amount the stock market is willing to pay for MPH Health Care's earnings, growth and assets is considered below, and whether this is a fair price.
Price based on past earnings
Are MPH Health Care's earnings available for a low price, and how does this compare to other companies in the same industry?
Raw Data
XTRA:93M PE (Price to Earnings) Ratio Data Sources
Data Point Source Value
Earnings Per Share * Company Filings (2018-06-30) in EUR €2.13
DB:93M Share Price ** DB (2019-04-18) in EUR €4.32
Germany Pharmaceuticals Industry PE Ratio Median Figure of 6 Publicly-Listed Pharmaceuticals Companies 26.82x
Germany Market PE Ratio Median Figure of 424 Publicly-Listed Companies 19.59x

* Trailing twelve months (TTM) annual GAAP earnings per share excluding extraordinary items.

** Primary Listing of MPH Health Care.

XTRA:93M PE (Price to Earnings) Ratio Calculation
Calculation Outcome
PE Ratio

= DB:93M Share Price ÷ EPS (both in EUR)

= 4.32 ÷ 2.13

2.03x

Learn more about our ratios and growth rates in Simply Wall St’s analysis model >

  • MPH Health Care is good value based on earnings compared to the DE Pharmaceuticals industry average.
  • MPH Health Care is good value based on earnings compared to the Germany market.
Price based on expected Growth
Does MPH Health Care's expected growth come at a high price?
Raw Data
XTRA:93M PEG (Price to Earnings to Growth) Ratio Data Sources
Data Point Source Value
PE Ratio See PE Ratio Section 2.03x
Net Income Annual Growth Rate See Future Growth Section.
Line of Best Fit* through Consensus Estimate Earnings of 0 Analysts
10.9%per year
Europe Pharmaceuticals Industry PEG Ratio Median Figure of 35 Publicly-Listed Pharmaceuticals Companies 1.76x
Germany Market PEG Ratio Median Figure of 270 Publicly-Listed Companies 1.56x

*Line of best fit is calculated by linear regression .

Learn more about our ratios and growth rates in Simply Wall St’s analysis model >

  • Unable to calculate PEG ratio for MPH Health Care, we can't assess if its growth is good value.
Price based on value of assets
What value do investors place on MPH Health Care's assets?
Raw Data
XTRA:93M PB (Price to Book) Ratio Data Sources
Data Point Source Value
Book Value per Share Company Filings (2018-06-30) in EUR €6.93
DB:93M Share Price * DB (2019-04-18) in EUR €4.32
Germany Pharmaceuticals Industry PB Ratio Median Figure of 9 Publicly-Listed Pharmaceuticals Companies 2.39x
Germany Market PB Ratio Median Figure of 574 Publicly-Listed Companies 1.84x
XTRA:93M PB (Price to Book) Ratio Calculation
Calculation Outcome
PB Ratio

= DB:93M Share Price ÷ Book Value per Share (both in EUR)

= 4.32 ÷ 6.93

0.62x

* Primary Listing of MPH Health Care.

Learn more about our ratios and growth rates in Simply Wall St’s analysis model >

  • MPH Health Care is good value based on assets compared to the DE Pharmaceuticals industry average.
X
Value checks
We assess MPH Health Care's value by looking at:
  1. Is the discounted cash flow value less than 20%, or 40% of the share price? (2 checks) ( Click here or on bar chart for details of DCF calculation. )
  2. Is the PE ratio less than the market average, and/ or less than the Pharmaceuticals industry average (and greater than 0)? (2 checks)
  3. Is the PEG ratio within a reasonable range (0 to 1)? (1 check)
  4. Is the PB ratio less than the Pharmaceuticals industry average (and greater than 0)? (1 check)
  5. MPH Health Care has a total score of 3/6, see the detailed checks below.

    Note: We use GAAP Earnings per Share in all our calculations including PE and PEG Ratio.

    Full details on the Value part of the Simply Wall St company analysis model.

Future Performance

 How is MPH Health Care expected to perform in the next 1 to 3 years based on estimates from 0 analysts?

  • No analysts cover MPH Health Care, future earnings growth has been estimated based on fundamentals.
The future performance of a company is measured in the same way as past performance, by looking at estimated growth and how much profit it is expected to make.

Future estimates come from professional analysts. Just like forecasting the weather, they don’t always get it right!
Annual Growth Rate
10.9%
Expected annual growth in earnings.
Earnings growth vs Low Risk Savings
Is MPH Health Care expected to grow at an attractive rate?
  • MPH Health Care's earnings growth is expected to exceed the low risk savings rate of 0.2%.
Growth vs Market Checks
  • MPH Health Care's earnings growth is positive but not above the Germany market average.
  • Unable to compare MPH Health Care's revenue growth to the Germany market average as no estimate data is available.
Annual Growth Rates Comparison
Raw Data
XTRA:93M Future Growth Rates Data Sources
Data Point Source Value (per year)
XTRA:93M Future Earnings Growth Rate Line of Best Fit* through Consensus Estimate Earnings of 0 Analysts 10.9%
Germany Pharmaceuticals Industry Earnings Growth Rate Market Cap Weighted Average 19.7%
Germany Pharmaceuticals Industry Revenue Growth Rate Market Cap Weighted Average 4.8%
Germany Market Earnings Growth Rate Market Cap Weighted Average 11.6%
Germany Market Revenue Growth Rate Market Cap Weighted Average 4.8%

*Line of best fit is calculated by linear regression .

Industry and Market average data is calculated daily.

Learn more about our growth rate calculations in Simply Wall St’s analysis model.

Analysts growth expectations
Raw Data
XTRA:93M Analysts Growth Expectations Data Sources
Data Point Source Value
Past Financials Company Filings (9 months ago) See Below
Future Estimates Average of up to 0 Analyst Estimates (S&P Global) See Below
All numbers in EUR Millions and using Trailing twelve months (TTM) annual period rather than quarterly.
XTRA:93M Future Estimates Data
Date (Data in EUR Millions) Revenue Cash Flow Net Income * Avg. No. Analysts
XTRA:93M Past Financials Data
Date (Data in EUR Millions) Revenue Cash Flow Net Income *
2018-06-30 50 -1 90
2018-03-31 25 0 61
2017-12-31 0 1 32
2017-09-30 4 -1 45
2017-06-30 1 0 58
2017-03-31 1 -3 69
2016-12-31 0 -5 80
2016-09-30 78 -2 90
2016-06-30 156 1 100
2016-03-31 210 1 91
2015-12-31 263 0 83
2015-09-30 239 1 43

*GAAP earnings excluding extraordinary items.

Super high growth metrics
High Growth Checks
  • MPH Health Care's earnings are expected to grow by 10.9% yearly, however this is not considered high growth (20% yearly).
  • Unable to determine if MPH Health Care is high growth as no revenue estimate data is available.
Past and Future Earnings per Share
The accuracy of the analysts who estimate the future performance data can be gauged below. We look back 3 years and see if they were any good at predicting what actually occurred. We also show the highest and lowest estimates looking forward to see if there is a wide range.
Raw Data
XTRA:93M Past and Future Earnings per Share
Data Point Source Value
Past Financials Company Filings (9 months ago) See Below
Future Estimates Average of up to 0 Analyst Estimates (S&P Global) See Below

All data from MPH Health Care Company Filings, last reported 9 months ago, and in Trailing twelve months (TTM) annual period rather than quarterly.

XTRA:93M Future Estimates Data
Date (Data in EUR Millions) EPS * EPS High Estimate EPS Low Estimate Avg. No. Analysts
XTRA:93M Past Financials Data
Date (Data in EUR Millions) EPS *
2018-06-30 2.13
2018-03-31 1.43
2017-12-31 0.74
2017-09-30 1.04
2017-06-30 1.34
2017-03-31 1.60
2016-12-31 1.87
2016-09-30 2.10
2016-06-30 2.34
2016-03-31 2.13
2015-12-31 1.93
2015-09-30 1.00

*GAAP earnings excluding extraordinary items.

Performance in 3 years
In the same way as past performance we look at the future estimated return (profit) compared to the available funds. We do this looking forward 3 years.
  • Unable to establish if MPH Health Care will efficiently use shareholders’ funds in the future without estimates of Return on Equity.
X
Future performance checks
We assess MPH Health Care's future performance by looking at:
  1. Is the annual earnings growth rate expected to beat the low risk savings rate, plus a premium to keep pace with inflation?
  2. Is the annual earnings growth rate expected to beat the average growth rate in earnings of the Germany market? (1 check)
  3. Is the annual revenue growth rate expected to beat the average growth rate in revenue of the Germany market? (1 check)
  4. Is the annual earnings growth rate expected to be above 20%? (1 check)
  5. Is the annual revenue growth rate expected to be above 20%? (1 check)
  6. Is the Return on Equity in 3 years expected to be over 20%? (1 check)
Some of the above checks will fail if the company is expected to be loss making in the relevant year.
MPH Health Care has a total score of 1/6, see the detailed checks below.

Note 1: We use GAAP Net Income Excluding Exceptional Items for our Earnings in all our calculations.

Full details on the Future part of the Simply Wall St company analysis model.

Past Performance

  How has MPH Health Care performed over the past 5 years?

  • MPH Health Care's last earnings update was 233 days ago.
The past performance of a company can be measured by how much growth it has experienced and how much profit it makes relative to the funds and assets it has available.
Past earnings growth
Below we compare MPH Health Care's growth in the last year to its industry (Pharmaceuticals).
Past Earnings growth analysis
We also check if the company has grown in the past 5 years, and whether it has maintained that growth in the year.
  • MPH Health Care has delivered over 20% year on year earnings growth in the past 5 years.
  • MPH Health Care's 1-year earnings growth exceeds its 5-year average (54.4% vs 38.1%)
  • MPH Health Care's earnings growth has exceeded the DE Pharmaceuticals industry average in the past year (54.4% vs 22%).
Earnings and Revenue History
MPH Health Care's revenue and profit over the past 5 years is shown below, any years where they have experienced a loss will show up in red.
Raw Data

All data from MPH Health Care Company Filings, last reported 9 months ago, and in Trailing twelve months (TTM) annual period rather than quarterly.

XTRA:93M Past Revenue, Cash Flow and Net Income Data
Date (Data in EUR Millions) Revenue Net Income * G+A Expenses R&D Expenses
2018-06-30 50.39 89.96 0.55
2018-03-31 25.23 60.91 0.53
2017-12-31 0.07 31.86 0.50
2017-09-30 4.40 45.05 0.58
2017-06-30 1.39 58.25 0.46
2017-03-31 0.72 69.16 0.51
2016-12-31 0.05 80.07 0.56
2016-09-30 78.13 89.99 2.89
2016-06-30 156.22 99.92 5.22
2016-03-31 209.55 91.25 6.77
2015-12-31 262.89 82.59 8.33
2015-09-30 238.63 42.64 9.16
2015-06-30 214.38 2.69 10.00
2015-03-31 216.81 3.82 8.24
2014-12-31 219.25 4.95 6.48
2014-09-30 225.64 5.86 6.15
2014-06-30 232.04 6.76
2014-03-31 229.44 6.60
2013-12-31 226.84 6.45 5.82
2013-09-30 222.82 9.21 2.91
2013-06-30 218.79 11.98
2013-03-31 212.25 13.35
2012-12-31 205.71 14.71
2012-09-30 190.13 12.65 1.24
2012-06-30 174.55 10.58 2.48

*GAAP earnings excluding extraordinary items.

Performance last year
We want to ensure a company is making the most of what it has available. This is done by comparing the return (profit) to a company's available funds, assets and capital.
  • MPH Health Care has efficiently used shareholders’ funds last year (Return on Equity greater than 20%).
  • MPH Health Care used its assets more efficiently than the DE Pharmaceuticals industry average last year based on Return on Assets.
  • MPH Health Care has significantly improved its use of capital last year versus 3 years ago (Return on Capital Employed).
X
Past performance checks
We assess MPH Health Care's performance over the past 5 years by checking for:
  1. Has earnings increased in past 5 years? (1 check)
  2. Has the earnings growth in the last year exceeded that of the Pharmaceuticals industry? (1 check)
  3. Is the recent earnings growth over the last year higher than the average annual growth over the past 5 years? (1 check)
  4. Is the Return on Equity (ROE) higher than 20%? (1 check)
  5. Is the Return on Assets (ROA) above industry average? (1 check)
  6. Has the Return on Capital Employed (ROCE) increased from 3 years ago? (1 check)
The above checks will fail if the company has reported a loss in the most recent earnings report. Some checks require at least 3 or 5 years worth of data.
MPH Health Care has a total score of 6/6, see the detailed checks below.

Note: We use GAAP Net Income excluding extraordinary items in all our calculations.

Full details on the Past part of the Simply Wall St company analysis model.

Health

 How is MPH Health Care's financial health and their level of debt?

A company's financial position is much like your own financial position, it includes everything you own (assets) and owe (liabilities).

The boxes below represent the relative size of what makes up MPH Health Care's finances.

The net worth of a company is the difference between its assets and liabilities.
Net Worth
  • MPH Health Care is able to meet its short term (1 year) commitments with its holdings of cash and other short term assets.
  • MPH Health Care's long term commitments exceed its cash and other short term assets.
Balance sheet
This treemap shows a more detailed breakdown of MPH Health Care's finances. If any of them are yellow this indicates they may be out of proportion and red means they relate to one of the checks below.
Assets
Liabilities and shares
The 'shares' portion represents any funds contributed by the owners (shareholders) and any profits.
  • Low level of unsold assets.
  • Debt is not covered by short term assets, assets are 0.6x debt.
Historical Debt
Nearly all companies have debt. Debt in itself isn’t bad, however if the debt is too high, or the company can’t afford to pay the interest on its debts this may have impacts in the future.

The graphic below shows equity (available funds) and debt, we ideally want to see the red area (debt) decreasing.

If there is any debt we look at the companies capability to repay it, and whether the level has increased over the past 5 years.
Raw Data

All data from MPH Health Care Company Filings, last reported 9 months ago.

XTRA:93M Past Debt and Equity Data
Date (Data in EUR Millions) Total Equity Total Debt Cash & Short Term Investments
2018-06-30 296.57 14.00 4.57
2018-03-31 296.57 14.00 4.57
2017-12-31 240.67 14.00 6.76
2017-09-30 240.67 14.00 6.76
2017-06-30 206.61 14.00 15.63
2017-03-31 206.61 14.00 15.63
2016-12-31 213.95 14.00 10.45
2016-09-30 213.95 14.00 10.45
2016-06-30 153.50 7.02 5.68
2016-03-31 153.50 7.02 5.68
2015-12-31 139.02 10.05 0.53
2015-09-30 139.02 10.05 0.53
2015-06-30 93.38 51.93 19.03
2015-03-31 93.38 51.93 19.03
2014-12-31 94.73 37.72 17.70
2014-09-30 94.73 37.72 17.70
2014-06-30 89.90 37.43 22.39
2014-03-31 89.90 37.43 22.39
2013-12-31 79.19 31.84 15.38
2013-09-30 79.19 31.84 15.38
2013-06-30 79.06 35.52 43.29
2013-03-31 79.06 35.52 43.29
2012-12-31 67.36 33.26 25.57
2012-09-30 67.36 33.26 25.57
2012-06-30 68.48 28.82 17.75
  • MPH Health Care's level of debt (4.7%) compared to net worth is satisfactory (less than 40%).
  • The level of debt compared to net worth has been reduced over the past 5 years (44.9% vs 4.7% today).
  • Operating cash flow is negative therefore debt is not well covered.
  • MPH Health Care earns more interest than it pays, coverage of interest payments is not a concern.
X
Financial health checks
We assess MPH Health Care's financial health by checking for:
  1. Are short term assets greater than short term liabilities? (1 check)
  2. Are short term assets greater than long term liabilities? (1 check)
  3. Has the debt to equity ratio increased in the past 5 years? (1 check)
  4. Is the debt to equity ratio over 40%? (1 check)
  5. Is the debt covered by operating cash flow? (1 check)
  6. Are earnings greater than 5x the interest on debt (if company pays interest at all)? (1 check)
  7. MPH Health Care has a total score of 4/6, see the detailed checks below.
For companies that are loss making and have been so on average in the past we replace the last 2 checks with:
  1. Does cash and short term investments cover stable operating expenses (recurring G&A and R&D) for more than 3 years? (1 check)
  2. Does cash and short term investments cover growing operating expenses (recurring G&A and R&D) for more than 3 years? (1 check)


Full details on the Health part of the Simply Wall St company analysis model.

Dividends

 What is MPH Health Care's current dividend yield, its reliability and sustainability?

Dividends are regular cash payments to you from the company, similar to a bank paying you interest on a savings account.
Annual Dividend Income
Dividend payments
4.63%
Current annual income from MPH Health Care dividends.
If you bought €2,000 of MPH Health Care shares you are expected to receive €93 in your first year as a dividend.
Dividend Amount
Here we look how much dividend is being paid, if any. Is it above what you can get in a savings account? It is up there with the best dividend paying companies?
  • MPH Health Care's pays a higher dividend yield than the bottom 25% of dividend payers in Germany (1.43%).
  • MPH Health Care's dividend is above the markets top 25% of dividend payers in Germany (3.71%).
Upcoming dividend payment

Purchase MPH Health Care before the 'Buy Limit' to receive their next dividend payment.

Dividends are usually paid every 3 or 6 months, you can time your share purchase to take advantage of upcoming dividend payments.
Dividend payment calendar
Annualized Historical and Future Dividends
It is important to see if the dividend for a company is stable, and not wildly increasing/decreasing each year. This graph shows you the historical rate to count toward your assessment of the stock.

We also check to see if the dividend has increased in the past 10 years.
Raw Data
XTRA:93M Annualized Past and Future Dividends
Data Point Source Value
Past Annualized Dividend Yield S&P Global Market Data See Below
Past Dividends per Share Company Filings/ Annualized Dividend Payments See Below
Future Dividends per Share Estimates Average of up to 0 Analyst Estimates (S&P Global) See Below
Germany Pharmaceuticals Industry Average Dividend Yield Market Cap Weighted Average of 5 Stocks 3%
Germany Market Average Dividend Yield Market Cap Weighted Average of 327 Stocks 3%
Germany Minimum Threshold Dividend Yield 10th Percentile 0.8%
Germany Bottom 25% Dividend Yield 25th Percentile 1.4%
Germany Top 25% Dividend Yield 75th Percentile 3.7%

Industry and Market average data is calculated daily.

Note all dividend per share amounts are annualized and not quarterly or other period.

XTRA:93M Future Dividends Estimate Data
Date (Data in €) Dividend per Share (annual) Avg. No. Analysts
XTRA:93M Past Annualized Dividends Data
Date (Data in €) Dividend per share (annual) Avg. Yield (%)
2018-07-13 0.200 4.648
2017-08-31 0.120 3.008
2017-04-28 0.120 3.263
2016-08-30 0.120 3.440
2016-05-09 0.120 4.696
2015-08-31 0.120 5.334
2015-05-15 0.120 5.398
2014-09-03 0.096 3.980

Learn more about our ratios and growth rates in Simply Wall St’s analysis model >

  • Whilst dividend payments have been stable, MPH Health Care has been paying a dividend for less than 10 years.
  • Dividend payments have increased, but MPH Health Care only paid a dividend in the past 5 years.
Current Payout to shareholders
What portion of MPH Health Care's earnings are paid to the shareholders as a dividend.
  • Dividends paid are thoroughly covered by earnings (10.7x coverage).
Future Payout to shareholders
  • Insufficient estimate data to determine if a dividend will be paid in 3 years and that it will be sustainable.
X
Income/ dividend checks
We assess MPH Health Care's dividend by checking for:
  1. Firstly is the company paying a notable dividend (greater than 0.8%) - if not then the rest of the checks are ignored.
  2. Is current dividend yield above the bottom 25% of dividend payers? (1 check)
  3. Is current dividend yield above the top 25% of dividend payers? (1 check)
  4. Have they paid a dividend for 10 years, and during this period has the dividend been volatile (drop of more than 25%)? (1 check)
  5. If they have paid a dividend for 10 years has it increased in this time? (1 check)
  6. How sustainable is the dividend, can MPH Health Care afford to pay it from its earnings today and in 3 years (Payout ratio less than 90%)? (2 checks)
  7. MPH Health Care has a total score of 3/6, see the detailed checks below.


Full details on the Dividends part of the Simply Wall St company analysis model.

Management

 What is the CEO of MPH Health Care's salary, the management and board of directors tenure and is there insider trading?

Management is one of the most important areas of a company. We look at unreasonable CEO compensation, how long the team and board of directors have been around for and insider trading.
CEO
Patrick Brenske
TENURE AS CEO 10.3 years
CEO Bio

Mr. Patrick Brenske has been the Chief Executive Officer of MPH Mittelständische Pharma Holding AG since January 23, 2009 and has been its Member of Management Board since 2009. Mr. Brenske serves as Chief Executive Officer at M1 Kliniken AG and has been its Member of the Management Board since June 26, 2015. He has experience in the pharmaceutical industry through his position as Director of Purchasing and Sales at HAEMATO PHARM AG, for which he is responsible since 2007. He served as Head Purchase and Sale at HAEMATO Pharm GmbH from 2007 to 2012. Mr. Brenske has gained his economical know-how through his studies at the American University, Washington D.C., and at the Frankfurt School of Finance & Management, where he received his Master of Science.

CEO Compensation
  • Insufficient data for Patrick to compare compensation growth.
  • Insufficient data for Patrick to establish whether their remuneration is reasonable compared to companies of similar size in Germany.
Management Team

Patrick Brenske

TITLE
CEO & Member of Management Board
TENURE
10.3 yrs
Board of Directors

Andrea Grosse

TITLE
Chairwoman of Supervisory Board
AGE
53
TENURE
9.1 yrs

Ulrich Wandschneider

TITLE
Deputy Chair of Supervisory Board
AGE
57
TENURE
1.6 yrs
Who owns this company?
Recent Insider Trading
  • No 3 month insider trading information.
Recent Insider Transactions
Announced Type Name Entity Role Start End Shares Max Price (€) Value (€)
X
Management checks
We assess MPH Health Care's management by checking for:
  1. Is the CEO's compensation unreasonable compared to market cap? (1 check)
  2. Has the CEO's compensation increased more than 20% whilst the EPS is down more then 20%? (1 check)
  3. Is the average tenure of the management team less than 2 years? (1 check)
  4. Is the average tenure of the board of directors team less than 3 years? (1 check)
  5. MPH Health Care has a total score of 0/6, this is not included on the snowflake, see the detailed checks below.


Note: We use the top 6 management executives and board members in our calculations.

Note 2: Insider trading include any internal stakeholders and these transactions .

Full details on the Management part of the Simply Wall St company analysis model.

News

Simply Wall St News

Company Info

Description

MPH Health Care AG operates in the healthcare market in Germany. It produces medicinal products for the therapies of cancer, HIV, and other chronic diseases. The company also offers medical aesthetic treatments; and develops and sells pharmaceutical and medical products, including botulinum toxin, hyaluronic acid, implants, and provides services, as well as medical devices for the aesthetic surgery and cosmetic dermatology. In addition, it is involved in the provision of cytostatic admixture and concomitant medications; and real estate activities. The company was formerly known as MPH Mittelständische Pharma Holding AG. MPH Health Care AG was founded in 2008 and is based in Berlin, Germany.

Details
Name: MPH Health Care AG
93M
Exchange: XTRA
Founded: 2008
€184,955,797
42,813,842
Website: http://www.mph-ag.de
Address: MPH Health Care AG
Grünauer Strasse 5,
Berlin,
Berlin, 12557,
Germany
Listings
Exchange Symbol Ticker Symbol Security Exchange Country Currency Listed on
DB 93M Common Stock Deutsche Boerse AG DE EUR 03. Sep 2014
XTRA 93M Common Stock XETRA Trading Platform DE EUR 03. Sep 2014
LSE 0W1Q Common Stock London Stock Exchange GB EUR 03. Sep 2014
Number of employees
Current staff
Staff numbers
351
MPH Health Care employees.
Industry
Pharmaceuticals
Pharmaceuticals & Biotech
Company Analysis and Financial Data Status
Area Date (UTC time)
Company Analysis updated: 2019/04/21 21:43
End of day share price update: 2019/04/18 00:00
Last estimates confirmation: 2018/05/09
Last earnings filing: 2018/08/31
Last earnings reported: 2018/06/30
Last annual earnings reported: 2017/12/31


All dates and times in UTC. All financial data provided by Standard & Poor’s Capital IQ.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.